Compare TOUR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOUR | IXHL |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | China | Australia |
| Employees | N/A | N/A |
| Industry | Transportation Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.1M | 63.3M |
| IPO Year | 2014 | 2024 |
| Metric | TOUR | IXHL |
|---|---|---|
| Price | $6.50 | $3.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 37.1K | ★ 309.0K |
| Earning Date | 06-11-2026 | 05-15-2026 |
| Dividend Yield | ★ 17.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000.00 |
| Revenue This Year | $17.30 | N/A |
| Revenue Next Year | $14.00 | N/A |
| P/E Ratio | $87.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.56 | $0.16 |
| 52 Week High | $7.79 | $6.39 |
| Indicator | TOUR | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 70.42 | 43.16 |
| Support Level | $0.69 | $0.34 |
| Resistance Level | $7.79 | $3.68 |
| Average True Range (ATR) | 0.25 | 0.32 |
| MACD | -0.20 | -0.14 |
| Stochastic Oscillator | 70.30 | 7.43 |
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.